Dr. Ashish Gupta Best Oncologist in Delhi at Amerix Cancer Hospital
Team of 10+ Oncologists Led by US Board-Certified Oncologist
- Medical Oncology
- Radiation Oncology
- Surgical Oncology
USA Trained Chief Medical Oncologist
Dr. Ashish Gupta
MD Internal Medicine, USA Triple Board Certified

- 2018 – 2021: ABIM Fellowship, Medical Oncology and Hematology, Roswell Park Comprehensive Cancer Centre, Buffalo, New York
- 2013 – 2016: MD, Internal Medicine, Univ of Houston Texas- MDAnderson Cancer Center, Brooklyn Hospital New York
- 2004 – 2010: MBBS (PGIMS), Rohtak, Haryana, India
- 2018 – 2021: ABIM Fellowship, Medical Oncology and Hematology, Roswell Park Comprehensive Cancer Centre, Buffalo, New York
- 2013 – 2016: MD, Internal Medicine, Univ of Houston Texas- MDAnderson Cancer Center, Brooklyn Hospital New York
- 2004 – 2010: MBBS (PGIMS), Rohtak, Haryana, India
About Dr. Ashish Gupta:
Dr Ashish Gupta is a medical oncologist and hematologist practicing in Delhi. He completed his MBBS from PGIMS Rohtak . He then did his MD in Internal Medicine from UT Houston/MD Anderson Cancer Centre in Houston, TX and Brooklyn Hospital, New York where he also served as Chief Resident.
He completed his fellowship in medical oncology and haematology from Roswell Park Comprehensive Cancer Centre in Buffalo New York, the world’s first cancer centre. He is ABIM USA board-certified in Internal Medicine and Medical Oncology and registered to practice in Delhi as well as the State of New York.
He is Chief of Medical Oncology at Unique Hospital Cancer Centre in Dwarka. He specializes in the management of solid tumors including Breast Cancer, Lung Cancer, Gastrointestinal and Hepatobiliary Cancers, Prostate Cancer, Bladder Cancer, Head and Neck Cancers and Gynecologic Cancers. He also has expertise in hematological malignancies like Lymphomas, Multiple Myeloma and Chronic Leukemias.
He has authored numerous manuscripts in international journals, presented at international conferences and written books. Topics include Lung Cancer, Breast Cancer, Multiple Myeloma, Wisdom in Oncology. He has published in Journal of Clinical Oncology, Precision Medicine; Cancers, JNCCN, Expert Review of Anticancer Therapy and has presented at numerous international conferences including: San Antonio Breast Cancer Conference (SABCS), National Comprehensive Cancer Network (NCCN) Annual Conference, American Association of Cancer Research (AACR). He is a member of American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and American Association of Cancer Research (AACR).
He is passionate about keeping the patient first and explaining in simple language the diagnosis, treatment options and prognosis to patients. In 2022 he served as one of the four Cancer GRACE USA Patient Education Ambassadors. He has also conducted a series of interviews with leaders in oncology and authored a book ‘Pearls of Wisdom in Oncology: Key Insights, Traits, and Best Practices’. His awards include Gold Humanism Honor Society Award, Chief Resident Award, Primary Care Award.
He has an active interest in integrating mind-body medicine into practice and is a certified Yoga Therapist from s-VYASA Yoga University, Bangalore.
Awards, Seminars & Conferences
- 2022: Gold Humanism Honor Society Award
University at Buffalo Hematology/Oncology Fellowship, Buffalo, NY - 2020: Primary Care Award
Internal Medical Residency Program, The Brooklyn Hospital Center, Brooklyn, NY
Publications
- 2023 - Gupta A, Jatwani K, Gupta K, Qiu J, Dy G. Loss of Rb1 associated with the onset of acquired resistance to Trastuzumab Deruxtecan in TP53/HER2 mutated NSCLC: Case Series. JCO Precision Oncology.
- 2022 - Gupta R*, Gupta A*, Hillengass J, Holstein SA, Suman VJ, Taneja A, McCarthy PL. A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022. Expert Review of Anticancer Therapy.
- 2022 - Gupta R, Roy AM, Gupta A, Takabe K, Dhakal A, Opyrchal M, Kalinski P, Gandhi S. Systemic Therapy De-escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era? Cancers.
- 2020 - Gupta A, Gupta R, O’Donnell J. How can physicians in training can tap into the wisdom of senior physicians? Journal of Cancer Education.
- 2019 - Gupta A, Patel P, Anwar R, Villanueva D, Vasudevan V, Guevara, E. Hypercoagulable workup in a community hospital setting: To test or not to test; that is the question. Journal of Community Hospital Internal Medicine Perspectives.
- 2019 - Gupta A, Elfiky AA. Current and Future Approaches to the Diagnosis, Staging, and Management of Advanced Adrenocortical Carcinoma. Discovery Medicine.
- 2019 - Gupta A, Patel P, Manvar K, Kellner T, Guevara E. Splenic Infarction in Babesiosis: A Rare Presentation. Clinical Case Reports.
- 2019 - Gupta K, Tun A, Gupta A, Berkowitz L, Anwar R, Liu Y, Guevara E. A Case of Classic Kaposi Sarcoma in an Immunocompetent HIV-Negative Dominican Man. Sage Open Medical Case Reports.
- 2019 - Rathnakumar G.R, Gupta A, John F, Liu Y, Shakil S, Guevara E. A Case of Gastric Small Cell Carcinoma with Metastases to Bone and Liver. Journal of Gastrointestinal Oncology.
- 2019 - Gupta A, Tun A, Ticona K, Baqui A, Guevara E. A Case of Pleural Aspergillosis Associated with Durvalumab Treatment for Advanced Non-Small Cell Lung Cancer. Case Reports in Oncological Medicine.
- 2012 - Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Chang I, Tanaka Y, Gupta A, Dahiya R. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis.
Latest News
Stories
Real Patient Stories
Why Choose Amerix Cancer Hospital?
World-Class American Cancer Care, Now in India
World-Class American Cancer Care, Now in India
CANCER CARE VIDEO LIBRARY
Hear From Our
Expert Oncologists
YOU'RE IN SAFE HANDS
Meet Amerix
Cancer Experts
Comprehensive cancer care led by US-trained Dr Ashish Gupta, offering medical, surgical, and radiation oncology.





1:1 Dedicated Support
Unlike other hospitals where patients often feel lost, our Care Navigators are here to:
- Explain each step of the treatment process.
- Coordinate with doctors and support teams.
- Answer questions and ease concerns for both patients and families.
Our expert team will reach out within 24 hours to guide your journey.
Speak to our Patient Counsellor
+91 78278-37031